Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data - Scorecard - MDSpire

Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data

  • By

  • Rodrigo Afonso da Silva Sardenberg

  • Carlos Augusto Lima de Campos

  • Breno Cordeiro Porto

  • Jose Arnaldo Shiomi da Cruz

  • March 4, 2026

  • 0 min

Share

Clinical Scorecard: Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data

At a Glance

CategoryDetail
Condition
Key MechanismsInclude specific statistics on late-stage presentation.
Target Population
Care Setting

Key Highlights

  • 5_year_survival_rate

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • I
      • n
      • c
      • l
      • u
      • d
      • e
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • e
      • x
      • a
      • m
      • p
      • l
      • e
      • s
      • o
      • f
      • h
      • e
      • a
      • l
      • t
      • h
      • c
      • a
      • r
      • e
      • u
      • t
      • i
      • l
      • i
      • z
      • a
      • t
      • i
      • o
      • n
      • m
      • e
      • t
      • r
      • i
      • c
      • s
      • .

      Risks

        Patient & Prescribing Data

        Clarify variability in molecular profiling.

        Clinical Best Practices

        • add_steps

        References

        Original Source(s)

        Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data

        • by Rodrigo Afonso da Silva Sardenberg, Carlos Augusto Lima de Campos, Breno Cordeiro Porto, Jose Arnaldo Shiomi da Cruz

        • March 4, 2026

        Related Content

        Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

        Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

        Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

        • May 28, 2026